Tacrolimus, cyclosporine and plasma lipoproteins in renal transplant recipients

Transplant International

Volumn 14, Issue 6, 2001, Pages 405-410

  Venkiteswaran, Kalas ^a   Sgoutas, D S ^a   Santanam, Nalini ^b   Neylan, John F ^c  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY CLINIC   (United States)

Author keywords

Cardiovascular disease; Cyclosporine; Lipoproteins; Renal transplantation; Tacrolimus

Indexed keywords

APOLIPOPROTEIN B; CYCLOSPORIN; CYCLOSPORIN A; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TACROLIMUS;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL;

ADULT; AGED; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 0035658101     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470100006     Document Type: Article

References (31)

1. Cyclosporine increases the oxidizability of low-densitylipoproteins in renal transplant recipients
2. Treatment of hyperlipidemia in renal transplant recipients
3. Effects of cyclosporine therapy on plasma lipoprotein levels
4. Increased lipid peroxidation in cyclosporin-treated heart transplant recipients
5. Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection
6. Cyclosporine low-density lipoproteins, and cholesterol
7. Lipid peroxides and antioxidant defenses in accelerated transplantation-associated coronary arteriosclerosis
8. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
9. Increased low density lipoprotein oxidation in stable kidney transplant recipients
10. The transport of cyclosporine in association with plasma lipoproteins in heart and liver transplant patients
11. Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia
12. The adverse impact of cyclosporine on serum lipids in renal transplant recipients
13. Relation of cyclosporine blood levels to adverse effects on lipoproteins
14. Development of an automated Lowry protein assay for the Cobas-Bio centrifugal analyzer
15. Effects of the immunosuppressive agent cyclosporine A on the production of apolipoprotein B containing lipoproteins
16. Electrophoretic separation of plasma lipoproteins in agarose gel
17. Adverse effect of cyclosporine on plasma cholesterol in renal transplant recipients
18. Paradoxical actions of antioxidants in the oxidation of low density lipoproteins by peroxidases
19. Interactions of cyclosporine A with human lipoproteins
20. Hyperlipidemia in long-term survivors of pediatric renal transplantation
21. Kidney transplantation under FK506
22. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
23. Oxidation of low density lipoproteins from patients with renal failure or renal transplants
24. Conversion from cyclosporine A to azathioprine treatment improves LDL oxidation in kidney transplant recipients
25. Oxidizability of low-density lipoproteins from neoral and tacrolimus-treated renal transplant patients
26. Lipid abnormalities in renal transplant recipients treated with cyclosporine
27. Dextran sulfate-Mg2 + precipitation procedure for quantitation of high-density-lipoprotein cholesterol
28. Distribution of FK506 in plasma lipoproteins in transplant patients